ATLAS GROWERS LTD. (“Atlas” or the “Company”), a wholly owned subsidiary of Atlas Biotechnologies Inc., announces the submission of its Affirmation of Readiness and Video Evidence Package (“Evidence Package”) to Health Canada. The submission of the Evidence Package is the final step related to the receipt of a cultivation license from Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The submission of the Evidence Package is a significant achievement for Atlas in its preparation to become a leading provider of medicinal cannabis.

President and Chief Executive Officer Sheldon Croome states; “We are extremely pleased to have submitted the required documentation to Health Canada to produce medicinal cannabis. With the completion of our state-of-the-art medicinal cannabis facility, development permits for up to 1,000,000 square feet of cultivation expansion (which utilizing proprietary technologies could be configured into 2,000,000 square feet of growing capacity) and recent additions to our Advisory Board with related experience in research and development, regulation and import and export, Atlas is well positioned to be a global leader in the cannabis industry.”


Health Canada inspections are conducted to assess and monitor compliance with the ACMPR, Controlled Drugs and Substances Act (CDSA) regulation and the Food and Drugs Act (FDA), as they apply to cannabis for medical purposes. It is anticipated that new cultivation licenses for the industry will be granted after October 17, 2018, the specified date for legalization of cannabis in Canada.

About Atlas Growers Ltd.

Atlas is based in Edmonton, Alberta, Canada and is a wholly owned subsidiary of Atlas Biotechnologies Inc. Atlas expects to receive its sales license by the end of 2018. Atlas’ initial purpose-built 38,000 square foot facility is in the final stages of equipping the growing rooms and labs and will have the capacity to produce approximately 5,000 kg of dried cannabis annually as well as to refine cannabis concentrates. Further, the 160-acre Atlas site could allow for significant future expansion of Atlas’ cultivation capacity. Atlas is well financed and has a currently unutilized $6.25 million bank facility in place with ATB Financial.

For further information contact:

Jeffrey R. Gossain, P. Eng.
Vice President of Operations
Phone: 780-784-5920
Email: jeff@atlasgrowers.com
Website: www.atlasgrowers.com

Graeme Dick, BMgmt
Colwell Capital Corp.
403-561-8989
graeme@colwellcapital.com

Dean Stuart
403-617-7609
dean@boardmarker.net

Source: globenewswire.com

Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market

PharmaCann is Well Positioned in Limited License States Across the Midwest and Northeast

Keep reading... Show less

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (the “ Company ” or “ Avicanna ”) (TSX: AVCN) announced today that it has been issued a Cease Trade Order (“ CTO ”) by the Ontario Securities Commission (the “ OSC ”) as it no longer expects to file the following periodic disclosure documents (collectively, the “ Documents ”) by June 11, 2021, as previously disclosed:

Keep reading... Show less

Adds two accomplished female directors to the Board

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the results of its Annual and Special Meeting of Shareholders held on June 10, 2021 (the “Meeting”). Each of the eight individuals nominated for election as a director of Trulieve at the Meeting were elected, including new nominees, Giannella Alvarez and Jane Morreau .

Keep reading... Show less

The National Football League (NFL) wants to know more about cannabis as a pain reliever, and it’s willing to put up an initial US$1 million for research.

Also this week, a cannabis operator announced plans to buy assets from a languishing producer.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company’s 89th nationwide.

The dispensary will be located next to the Citrus Park Town Center and helps meet Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The facility joins four other Tampa dispensaries, as well as several more in nearby Clearwater , St. Petersburg , and Largo.

Keep reading... Show less